Turn Therapeutics Inc. (TTRX)
Oxford Ledge is still expanding full research coverage of TTRX. A live quote, fundamentals, and analysis are available in the app; the SEC-sourced material below is what we currently have indexed here.
Business summary
Turn Therapeutics develops topical PHMB-based treatments for eczema and fungal nail infections, leveraging prior medical device clearances.
SEC filings
- 8-K Regulation FD disclosure; Financial statements and exhibits 2026-07-07
- 8-K Regulation FD disclosure; Financial statements and exhibits 2026-06-03
- 8-K Regulation FD disclosure; Financial statements and exhibits 2026-06-01
- 8-K Regulation FD disclosure; Financial statements and exhibits 2026-05-27
- 8-K Regulation FD disclosure; Financial statements and exhibits 2026-05-19
Source: SEC EDGAR.
Insider activity
5 recent insider (SEC Form 4) filings on record for TTRX. View the transactions in the terminal.
Source: SEC EDGAR (Form 4).
- Open TTRX in the Oxford Ledge terminal — live quote, chart, and analysis in the app.
- Browse the covered-stock index
- Learn to analyze stocks yourself
The material above is drawn from public SEC EDGAR filings and is provided for educational purposes, not as investment advice. Live pricing and fundamentals are available in the terminal.